{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T22:41:32Z","timestamp":1792363292187,"version":"4.4.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:00:00Z","timestamp":1792368000000},"content-version":"vor","delay-in-days":89,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-16246-1","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T08:35:36Z","timestamp":1784709336000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Characterizing the spatiotemporal displacement of fiducial markers for cyberknife radiosurgery in liver cancer and identifying predictive factors"],"prefix":"10.1186","volume":"26","author":[{"given":"Miaomiao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dengcui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guihua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"issue":"3","key":"16246_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"16246_CR2","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","volume":"7","author":"JM Llovet","year":"2021","unstructured":"Llovet JM, Kelley RK, Villanueva A. Hepatocellular carcinoma. Nat Rev Dis Primers. 2021;7(1):6.","journal-title":"Nat Rev Dis Primers"},{"issue":"10","key":"16246_CR3","doi-asserted-by":"publisher","first-page":"4551","DOI":"10.21873\/anticanres.17284","volume":"44","author":"K Matsubara","year":"2024","unstructured":"Matsubara K, Kobayashi T, Tadokoro T, Namba Y, Fukuhara S, Oshita KO, Honmyo N, Kuroda S, Arihiro K, Ohdan H. The Dominant Component and Clinicopathological Characteristics of Combined Hepatocellular-cholangiocarcinoma After Radical Resection. Anticancer Res. 2024;44(10):4551\u20139.","journal-title":"Anticancer Res"},{"issue":"7","key":"16246_CR4","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1111\/1754-9485.13309","volume":"65","author":"MD Shanker","year":"2021","unstructured":"Shanker MD, Moodaley P, Soon W, Liu HY. Stereotactic ablative radiotherapy for hepatocellular carcinoma: A systematic review and meta-analysis of local control, survival and toxicity outcomes. J Med Imaging Radiat Oncol. 2021;65(7):956\u201368.","journal-title":"J Med Imaging Radiat Oncol"},{"issue":"4","key":"16246_CR5","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1111\/jgh.15175","volume":"36","author":"MD Shanker","year":"2021","unstructured":"Shanker MD, Liu HY, Lee YY, Stuart KA, Powell EE. Stereotactic radiotherapy for hepatocellular carcinoma: Expanding the multidisciplinary armamentarium. J Gastroenterol Hepatol. 2021;36(4):873\u201384.","journal-title":"J Gastroenterol Hepatol"},{"issue":"4","key":"16246_CR6","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.semradonc.2005.04.005","volume":"15","author":"LA Dawson","year":"2005","unstructured":"Dawson LA, Ten Haken RK. Partial volume tolerance of the liver to radiation. Semin Radiat Oncol. 2005;15(4):279\u201383.","journal-title":"Semin Radiat Oncol"},{"issue":"3","key":"16246_CR7","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1111\/1754-9485.13020","volume":"64","author":"KM Lo","year":"2020","unstructured":"Lo KM, Wu VW. Factors affecting target motion in stereotactic body radiotherapy of liver cancer using CyberKnife. J Med Imaging Radiat Oncol. 2020;64(3):408\u201313.","journal-title":"J Med Imaging Radiat Oncol"},{"issue":"6","key":"16246_CR8","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1097\/COC.0b013e3180ca7cb1","volume":"30","author":"BK Chang","year":"2007","unstructured":"Chang BK, Timmerman RD. Stereotactic body radiation therapy: a comprehensive review. Am J Clin Oncol. 2007;30(6):637\u201344.","journal-title":"Am J Clin Oncol"},{"issue":"5","key":"16246_CR9","doi-asserted-by":"publisher","first-page":"5054","DOI":"10.3390\/curroncol30050382","volume":"30","author":"M Moskalenko","year":"2023","unstructured":"Moskalenko M, Jones BL, Mueller A, Lewis S, Shiao JC, Zakem SJ, Robin TP, Goodman KA. Fiducial Markers Allow Accurate and Reproducible Delivery of Liver Stereotactic Body Radiation Therapy. Curr Oncol. 2023;30(5):5054\u201361.","journal-title":"Curr Oncol"},{"issue":"4","key":"16246_CR10","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3857\/roj.2020.00472","volume":"38","author":"D Dutta","year":"2020","unstructured":"Dutta D, Kataki KJ, George S, Reddy SK, Sashidharan A, Kannan R, Madhavan R, Nair H, Tatineni T, Holla R. Prospective evaluation of fiducial marker placement quality and toxicity in liver CyberKnife stereotactic body radiotherapy. Radiat Oncol J. 2020;38(4):253\u201361.","journal-title":"Radiat Oncol J"},{"issue":"11","key":"16246_CR11","doi-asserted-by":"publisher","first-page":"5482","DOI":"10.1002\/mp.14501","volume":"47","author":"Z Liang","year":"2020","unstructured":"Liang Z, Zhou Q, Yang J, Zhang L, Liu D, Tu B, Zhang S. Artificial intelligence-based framework in evaluating intrafraction motion for liver cancer robotic stereotactic body radiation therapy with fiducial tracking. Med Phys. 2020;47(11):5482\u20139.","journal-title":"Med Phys"},{"issue":"2","key":"16246_CR12","doi-asserted-by":"publisher","first-page":"263","DOI":"10.17998\/jlc.2024.06.03","volume":"24","author":"S Hwang","year":"2024","unstructured":"Hwang S, Chun SJ, Chie EK, Lee JM. Assessment of real-time US-CT\/MR-guided percutaneous gold fiducial marker implementation in malignant hepatic tumors for stereotactic body radiation therapy. J Liver Cancer. 2024;24(2):263\u201373.","journal-title":"J Liver Cancer"},{"issue":"1116","key":"16246_CR13","doi-asserted-by":"publisher","first-page":"20200859","DOI":"10.1259\/bjr.20200859","volume":"93","author":"LB Stick","year":"2020","unstructured":"Stick LB, Vogelius IR, Risum S, Josipovic M. Intrafractional fiducial marker position variations in stereotactic liver radiotherapy during voluntary deep inspiration breath-hold. Br J Radiol. 2020;93(1116):20200859.","journal-title":"Br J Radiol"},{"issue":"2","key":"16246_CR14","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/j.1754-9485.2012.02445.x","volume":"57","author":"A Patel","year":"2013","unstructured":"Patel A, Khalsa B, Lord B, Sandrasegaran K, Lall C. Planting the seeds of success: CT-guided gold seed fiducial marker placement to guide robotic radiosurgery. J Med Imaging Radiat Oncol. 2013;57(2):207\u201311.","journal-title":"J Med Imaging Radiat Oncol"},{"issue":"6","key":"16246_CR15","first-page":"344","volume":"60","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2007;60(6):344\u20139.","journal-title":"J Clin Epidemiol"},{"key":"16246_CR16","doi-asserted-by":"publisher","first-page":"1021119","DOI":"10.3389\/fonc.2022.1021119","volume":"12","author":"X Sun","year":"2022","unstructured":"Sun X, Dai Z, Xu M, Guo X, Su H, Li Y. Quantifying 6D tumor motion and calculating PTV margins during liver stereotactic radiotherapy with fiducial tracking. Front Oncol. 2022;12:1021119.","journal-title":"Front Oncol"},{"issue":"1","key":"16246_CR17","doi-asserted-by":"publisher","first-page":"121","DOI":"10.2307\/2531248","volume":"42","author":"SL Zeger","year":"1986","unstructured":"Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics. 1986;42(1):121\u201330.","journal-title":"Biometrics"},{"key":"16246_CR18","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-19425-7","volume-title":"Regression Modeling Strategies: With Applications to Linear Models","author":"FE Harrell Jr","year":"2015","unstructured":"Harrell FE Jr. Regression Modeling Strategies: With Applications to Linear Models. Logistic and Survival Regression: Springer; 2015."},{"issue":"2","key":"16246_CR19","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.ijrobp.2006.01.050","volume":"65","author":"TR Willoughby","year":"2006","unstructured":"Willoughby TR, Kupelian PA, Pouliot J, Shinohara K, Aubin M, Roach M 3rd, Skrumeda LL, Balter JM, Litzenberg DW, Hadley SW, et al. Target localization and real-time tracking using the Calypso 4D localization system in patients with localized prostate cancer. Int J Radiat Oncol Biol Phys. 2006;65(2):528\u201334.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"16246_CR20","doi-asserted-by":"crossref","unstructured":"Motley R, Ramachandran P. A feasibility study on the development and use of a deep learning model to automate real-time monitoring of tumor position and assessment of interfraction fiducial marker migration in prostate radiotherapy patients. Biomed Phys Eng Express. 2022;8(3):10.","DOI":"10.1088\/2057-1976\/ac34da"},{"key":"16246_CR21","doi-asserted-by":"crossref","unstructured":"Kord M, Kluge A, Kufeld M, Kalinauskaite G, Loebel F, Stromberger C, Budach V. Risks and Benefits of Fiducial Marker Placement in Tumor Lesions for Robotic Radiosurgery: Technical Outcomes of 357 Implantations. Cancers (Basel). 2021;13(19):4838.","DOI":"10.3390\/cancers13194838"},{"issue":"3","key":"16246_CR22","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1002\/acm2.12292","volume":"19","author":"Z Liang","year":"2018","unstructured":"Liang Z, Liu H, Xue J, Hu B, Zhu B, Li Q, Zhang S, Wu G. Evaluation of the intra- and interfractional tumor motion and variability by fiducial-based real-time tracking in liver stereotactic body radiation therapy. J Appl Clin Med Phys. 2018;19(3):94\u2013100.","journal-title":"J Appl Clin Med Phys"},{"issue":"1130","key":"16246_CR23","doi-asserted-by":"publisher","first-page":"20210594","DOI":"10.1259\/bjr.20210594","volume":"95","author":"L Beaton","year":"2022","unstructured":"Beaton L, Daly M, Tregidgo HF, Grimes H, Moinuddin S, Stacey C, Znati S, Hague J, Bascal ZA, Wilde PE, et al. Radiopaque drug-eluting embolisation beads as fiducial markers for stereotactic liver radiotherapy. Br J Radiol. 2022;95(1130):20210594.","journal-title":"Br J Radiol"},{"key":"16246_CR24","doi-asserted-by":"crossref","unstructured":"Tadimalla S, Wang W. Role of Functional MRI in Liver SBRT: Current Use and Future Directions. Cancers (Basel). 2022;14(23):5860.","DOI":"10.3390\/cancers14235860"},{"issue":"8","key":"16246_CR25","doi-asserted-by":"publisher","first-page":"e70147","DOI":"10.1002\/acm2.70147","volume":"26","author":"VN Malkov","year":"2025","unstructured":"Malkov VN, Kemp BJ, Ferrero A, Buchholtz L, Park SS, Kavanaugh JA. Adaptive-driven CT simulation-free multi-fraction SBRT radiotherapy: Initial clinical experience. J Appl Clin Med Phys. 2025;26(8):e70147.","journal-title":"J Appl Clin Med Phys"},{"key":"16246_CR26","doi-asserted-by":"publisher","first-page":"1030599","DOI":"10.3389\/fonc.2023.1030599","volume":"13","author":"H Xu","year":"2023","unstructured":"Xu H, Zhang Z, Tian B, Li X, Bian Y, Liang X, Bo C. Evaluation of corrective effect of 6 degree of freedom couch on setup errors in intensity modulated radiotherapy for postoperative rectal cancer patients. Front Oncol. 2023;13:1030599.","journal-title":"Front Oncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-16246-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16246-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16246-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T22:31:52Z","timestamp":1792362712000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-16246-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["16246"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-16246-1","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,22]]},"assertion":[{"value":"24 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This retrospective study involving human participants was approved by the Ethics Committee of The First Hospital of Hebei Medical University (Approval No. 20250405). The requirement for informed consent was waived by the Ethics Committee of The First Hospital of Hebei Medical University due to the retrospective nature of the study. All procedures were performed in accordance with relevant guidelines and regulations, including the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1242"}}